Skip to main content
. 2021 Jan 1;11(2):754–767. doi: 10.7150/thno.51154

Figure 1.

Figure 1

Non-targeted metabolomics profiling analysis for human plasma. PLS-DA score plots from the healthy and psoriasis groups in (A) positive mode and (B) negative mode. Validation plots were obtained from 200 permutation tests in (A) positive mode (R2 = 0.791, Q2 = 0.291) and (B) negative mode (R2 = 0.839, Q2 = 0.458). (C and D) Metabolomics profiling annotation using database searching and metabolic network analysis to explore the corresponding identification and functional enrichment.